Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feedercanada.ca
Health Canada RSS - Drug Products, Drugs and Health Products
Get the latest updates from Health Canada RSS - Drug Products, Drugs and Health Products directly as they happen.
Follow now 263 followers
Latest posts
Last updated 3 days ago
Pharmaceutical and Life Sciences Sector Task Force: Report to the ministers of health and industry
3 days ago
This report presents the advice from the co-chairs of the task force...
Consultation on a proposed pilot approach to prioritize certain generic drug submissions involving domestic manufacturing within the review queue
12 days ago
Health Canada is seeking feedback on a proposed pilot approach to prioritize...
Improving access to drugs
12 days ago
Health Canada is encouraging the introduction of new drugs (therapies, treatments, and...
Consultation on draft guidance on Ministerial Reliance Order for certain human and veterinary drugs
12 days ago
Health Canada is seeking feedback on draft guidance on the Ministerial Reliance...
The Ministerial Reliance Order
12 days ago
The Ministerial Reliance Order (the Order) allows Health Canada to rely on...
What we heard: Draft guidance on decentralized clinical trials
about 2 months ago
Health Canada published the Draft guidance on Decentralized Clinical Trials on December...
Summary Basis of Decision for Ziihera
about 2 months ago
Health Canada Summary Basis of Decision 2026-03-30. Ziihera, zanidatamab, 300 mg/vial, powder...
Summary Basis of Decision for Voxzogo
about 2 months ago
Health Canada Summary Basis of Decision 2026-04-09. Voxzogo, vosoritide, 0.4 mg/vial, 0.56...
Summary Basis of Decision for Tryngolza
about 2 months ago
Health Canada Summary Basis of Decision 2026-04-13. Tryngolza, 80 mg/0.8 mL olezarsen...
Summary Basis of Decision for Redemplo
about 2 months ago
Health Canada Summary Basis of Decision 2026-04-07. Redemplo, 25 mg/0.5 mL plozasiran...
Summary Basis of Decision for Eydenzelt
about 2 months ago
Health Canada Summary Basis of Decision 2026-03-17. Eydenzelt, aflibercept, 2 mg/0.05 mL...
Revised post notice of compliance changes quality guidances: ICH Q12 interim implementation for biologics and Schedule C drugs
2 months ago
Health Canada is implementing ICH Q12 in a phased manner, with an...